Mergers and Acquisitions to Drive the Radiofrequency Ablation Devices Market | Technavio

Technavio has published a new market research report on the global radiofrequency ablation devices market from 2018-2022. (Graphic: Business Wire)

LONDON--()--Technavio market research analysts forecast the global radiofrequency ablation devices market to grow at a CAGR of close to 9% during the period 2018-2022, according to their latest report.

In this report, Technavio highlights the increasing M&A activity as one of the key emerging trends in the global radiofrequency ablation devices market. M&A improve the product portfolio of players, which results in product expansion and differentiation. Major players in the market are acquiring small players for their technologies, products, and partnerships with distributors. Such initiatives will change the market dynamics and consolidate the position of the acquiring companies.

This report is available at a USD 1,000 discount for a limited time only: View market snapshot before purchasing

Save more with Technavio. Buy 2 reports and get the third for FREE: View all Technavio’s current offers

In this report, Technavio analysts highlight the use of M2M technology for remote patient monitoring as a key factor contributing to the growth of the global radiofrequency ablation devices market:

Increasing prevalence of chronic disease and growth of geriatric population

The prevalence of chronic diseases is increasing among the geriatric population due to declining mortality rates. Countries such as Germany, 840,319 people above the age of 65 consulted a general physician. Hypertension was the most common cause of these visits. Stroke was the least common cause. More than one out of two people who visited a general physician had three chronic diseases.

According to a senior analyst at Technavio for cardiovascular diseases, “The sedentary lifestyle and changing eating habits of people make susceptible to chronic diseases such as heart disease, stroke, cancer, arthritis, and chronic pain such as low back pain and knee pain. According to research analysis, majority of the people with chronic pain have pain in different areas. In countries such as the US, the most common types of pain among adults is low back pain, knee pain, shoulder pain, finger pain, and hip pain. Radiofrequency ablation devices are used to treat these chronic diseases. Hence, the increasing prevalence of chronic diseases and the growth of the geriatric population will drive the growth of the global radiofrequency ablation devices market.”

Looking for more information on this market? Request a free sample report

Technavio’s sample reports are free of charge and contain multiple sections of the report such as the market size and forecast, drivers, challenges, trends, and more.

Global radiofrequency ablation devices market segmentation

This market research report segments the global radiofrequency ablation devices market into the following products (radiofrequency ablation systems, radiofrequency ablation catheters, and radiofrequency ablation consumables), applications (oncology, cardiovascular, gynecology, pain management and dermatology, and cosmetology), end-users (hospitals, ASCs, and physician offices), and key regions (the Americas, APAC, and EMEA).

Of the three major products, the radiofrequency ablation consumables segment held the largest market share in 2017, accounting for nearly 47% of the market. The market share for this product is expected to increase nearly 6% by 2022. The fastest growing product is radiofrequency ablation catheters, which will account for nearly 16% of the total market share by 2022.

The Americas was the leading region for the global radiofrequency ablation devices market in 2017, accounting for a market share of nearly 44%. By 2022, APAC is expected to register the highest growth of nearly 4%.

 

Save big with Technavio this May!

 

Find out what companies are venturing in to beat the heat this summer! Technavio indulges you with a massive 20% OFF on all non-alcoholic beverages reports for the entire month.

 

OR

 

Technavio honors the achievements and efforts of Motherhood this Mother's Day by offering a whopping 30% OFF on all cosmetics and toiletry reports. Offer valid from 7th May for a limited period.

About Technavio

Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.

With over 500 specialized analysts, Technavio’s report library consists of more than 10,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

If you are interested in more information, please contact our media team at media@technavio.com.

Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
www.technavio.com

Release Summary

Technavio market research analysts forecast the global radiofrequency ablation devices market to grow at a CAGR of close to 9% during 2018-2022.

Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
www.technavio.com